Author

Joaquim Peraire

Observed names: J Peraire, J. PERAIRE, J. Peraire, Joaquin Peraire, Joaquín Peraire, Peraire, Joaquim

Institutions: Instituto de Salud Carlos III, Institut de Recerca Biomèdica Catalunya Sud, Centro de Investigación Biomédica en Red, Hospital Universitari Joan XXIII de Tarragona, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Universitat Rovira i Virgili

Observed institutions: Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Hospital de Sant Pau, University Hospital Mútua de Terrassa, Maresme Health Consortium, Institut de Recerca Biomèdica Catalunya Sud, Hospital General de Granollers, Centro de Investigación Biomédica en Red, Mútua Terrassa, Hospital Del Mar, Hospital de Mataró, Hospital General Universitario de Alicante Doctor Balmis, Hospital Universitari Joan XXIII de Tarragona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Universitat Rovira i Virgili, Universitat de Barcelona

ORCID: 0000-0001-7808-5479

Observed ORCID: 0000-0001-7808-5479

OpenAlex ID: A5109929652

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

2021 · Daniel K Nomah, Juliana Reyes-Urueña, et al. · The Lancet HIV · 106

PDF

Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection

2019 · Laura Tarancon-Diez, Esther Rodríguez-Gallego, et al. · EBioMedicine · 78

PDF

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

2020 · Sergio Serrano-Villar, Javier Martínez-Sanz, et al. · The Lancet HIV · 62

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

2023 · Javier Martínez-Sanz, Jorge Díaz-Álvarez, et al. · EBioMedicine · 51

PDF

Pharmacogenetics of adverse effects due to antiretroviral drugs.

2010 · Francesc Vidal, Félix Gutiérrez, et al. · PubMed · 47

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

2016 · Juan Berenguer, Antonio Rivero, et al. · Open Forum Infectious Diseases · 42

PDF

A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients

2017 · Esther Rodríguez-Gallego, Josep Gómez, et al. · AIDS · 41

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

2019 · JM Llibre, A Montoliu, et al. · HIV Medicine · 39

PDF

Proximal tubular kidney damage and tenofovir

2004 · Maria Saumoy, Francesc Vidal, et al. · AIDS · 37

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

2023 · Inés Suárez-García, Belén Alejos, et al. · Journal of Antimicrobial Chemotherapy · 36

PDF

Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review

2021 · Jorge Palacio-Vieira, Juliana Maria Reyes-Urueña, et al. · BMC Public Health · 35

PDF

Fatal Listeria Meningitis, Endocarditis and Pericarditis in a Patient with Haemochromatosis

1997 · Cristina Manso, Imma Rivas, et al. · Scandinavian Journal of Infectious Diseases · 35

Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

2014 · E Martinez, A Gonzalez‐Cordon, et al. · HIV Medicine · 33

Spanish HIV-1-Infected Long-Term Nonprogressors of More Than 15 Years Have an Increased Frequency of the CX3CR1 249I Variant Allele

2005 · Francesc Vidal, Consuelo Viladés, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 33

Post-Exposure Prophylaxis for HIV Infection: A Clinical Trial Comparing Lopinavir/Ritonavir versus Atazanavir Each with Zidovudine/Lamivudine

2011 · Vicens Diaz–Brito, Agathe León, et al. · Antiviral Therapy · 32

Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy

2012 · Sergi Veloso, Xavier Escoté, et al. · Cytokine · 31

Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control

2018 · Esther Rodríguez-Gallego, Laura Tarancón-Diez, et al. · The Journal of Infectious Diseases · 30

PDF

High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients

2020 · Elena Yeregui, Consuelo Viladés, et al. · EBioMedicine · 29

Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial

2014 · Esteban Martinez, Esteban Martinez, et al. · Clinical Infectious Diseases · 29

PDF

Adipogenic/Lipid, Inflammatory, and Mitochondrial Parameters in Subcutaneous Adipose Tissue of Untreated HIV-1–Infected Long-Term Nonprogressors

2012 · Francesc Vidal, Pere Domingo, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 28

Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards

2010 · Sergi Veloso, Montserrat Olona, et al. · BMC Medical Genetics · 28

PDF

HIV-1-Infected Long-Term Non-Progressors have Milder Mitochondrial Impairment and Lower Mitochondrially-Driven Apoptosis in Peripheral Blood Mononuclear Cells than Typical Progressors

2007 · Joaquim Peraire, Oscar Miro, et al. · Current HIV Research · 28

Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial

2025 · Pablo Ryan, José L Blanco, et al. · The Lancet HIV · 27

Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study

2021 · Javier Martínez‐Sanz, José‐Ramón Blanco, et al. · Journal of the International AIDS Society · 27

Rat hepatitis E virus ( Rocahepevirus ratti ) in people living with HIV

2023 · María Casares-Jimenez, Antonio Rivero-Juarez, et al. · Emerging Microbes & Infections · 25

PDF

Works count: 133

Citation count: 1,813

H-index: 25

I10-index: 67